247 related articles for article (PubMed ID: 21224362)
1. Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases.
Klamp T; Schumacher J; Huber G; Kühne C; Meissner U; Selmi A; Hiller T; Kreiter S; Markl J; Türeci Ö; Sahin U
Cancer Res; 2011 Jan; 71(2):516-27. PubMed ID: 21224362
[TBL] [Abstract][Full Text] [Related]
2. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
3. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
4. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
5. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
6. CɛmX peptide-carrying HBcAg virus-like particles induced antibodies that down-regulate mIgE-B lymphocytes.
Lin CJ; Chen NY; Chen JB; Lu CS; Hung AF; Shiung YY; Wu PC; Pan RL; Chang TW
Mol Immunol; 2012 Oct; 52(3-4):190-9. PubMed ID: 22706073
[TBL] [Abstract][Full Text] [Related]
7. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.
Sahin U; Koslowski M; Dhaene K; Usener D; Brandenburg G; Seitz G; Huber C; Türeci O
Clin Cancer Res; 2008 Dec; 14(23):7624-34. PubMed ID: 19047087
[TBL] [Abstract][Full Text] [Related]
8. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
Tindle RW; Herd K; Londoño P; Fernando GJ; Chatfield SN; Malcolm K; Dougan G
Virology; 1994 May; 200(2):547-57. PubMed ID: 7513919
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
10. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
[TBL] [Abstract][Full Text] [Related]
11. Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope.
Kazaks A; Balmaks R; Voronkova T; Ose V; Pumpens P
Biotechnol J; 2008 Nov; 3(11):1429-36. PubMed ID: 18956370
[TBL] [Abstract][Full Text] [Related]
12. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.
Milich DR; Jones JE; Hughes JL; Maruyama T; Price J; Melhado I; Jirik F
J Immunol; 1994 Jan; 152(2):455-66. PubMed ID: 8283030
[TBL] [Abstract][Full Text] [Related]
13. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
14. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
[TBL] [Abstract][Full Text] [Related]
15. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
[TBL] [Abstract][Full Text] [Related]
17. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.
Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y
Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455
[TBL] [Abstract][Full Text] [Related]
18. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
[TBL] [Abstract][Full Text] [Related]
19. Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice.
Shu C; Sun P; Xie H; Huang W; Qi J; Ma Y
Int J Nanomedicine; 2020; 15():1983-1996. PubMed ID: 32308382
[TBL] [Abstract][Full Text] [Related]
20. Screen of multifunctional monoclonal antibodies against hepatitis B core virus-like particles.
Sun C; Ding FX; Wang F; He XW; He Y; Li ZS; Sun SH
Microbiol Immunol; 2009 Jun; 53(6):340-8. PubMed ID: 19493202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
